09/14/2021 | Press release | Distributed by Public on 09/15/2021 00:36
Interventions, including CBT, are now shown to be effective in the treatment of these conditions
Washington, DC, September 15, 2021
Depression in children and adolescents has become a major, global, public health challenge, with several negative health outcomes-many of which manifest themselves later in adulthood. A new study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, investigates subthreshold depression, a more severe form of depression that includes not only sad mood, but also some of the other symptoms of depression, and reports that psychological interventions may have a modest, but significant effect on the treatment of this type of depression in adolescents.
Characterized by clinically relevant symptoms that do not meet criteria for a depressive disorder, subthreshold depression can still have functionally impairing effects, leading to an increased risk of experiencing a major depression event and personal suffering.
Lead author, Pim Cuijpers, Professor of Clinical Psychology, Vrije Universiteit Amsterdam in the Netherlands said: 'It has become increasingly clear that depression can be best viewed as a continuum-ranging from no depression at all, to very severe at the other end-and many different states in between. Because the prevalence can be seen as much higher than the frequency of major depression, subthreshold depression is associated with a considerable disease burden on the population level and has also been found to be associated with the development of major depression and other mental disorders.'
While there have been several randomized trials examining the effects of psychological interventions on subthreshold depression in children and adolescents, these studies have not all resulted in the same outcomes.
To connect the dots between the existing research, the authors conducted an extensive search of bibliographic databases, and identified 12 studies examining psychological interventions for subthreshold depression in children and adolescents. With a total of 1,576 participants, these earlier outcomes were compared with usual care or other control conditions. Some studies also provided longer follow-up measurements to examine how many participants developed a depressive disorder over time.
The authors found that most studies focused on adolescents and only two examined children below 12 years of age, which meant there was not enough data to provide evidence on the effects of subthreshold depression in children.
For adolescents however, a significant effect was found for the psychological interventions. The effect size was moderate (with a standardized mean difference of 0.38), indicating that approximately eight adolescents had to be treated in order to have one more positive outcome than no treatment at all. When studies with low quality were excluded very comparable effects were found.
The overall findings also uncovered some indications for 'publication bias', a phenomenon that results in negative studies being overlooked (or not published at all), as they do not promote results that show a significant finding. After statistical adjustment for this type of bias, the effects were considerably smaller (standardized mean difference of 0.24).
No significant effect was found on the incidence of new cases of major depression at follow-up. Although the results pointed in the expected direction (the risk to develop a depressive disorder was reduced to approximately 50% in the treatments) this was not significant. This finding could be related to the small number of studies examining this outcome.
Overall, this study shows that interventions for subthreshold depression may have positive effects in adolescents. At this point in time however, there is insufficient evidence that these interventions are effective in children less than 12 years of age, or that they prevent the onset of major depression at follow-up.
Notes for editors
The article is 'A Meta-analytic Review: Psychological Treatment of Subthreshold Depression in Children and Adolescents,' by Pim Cuijpers, PhD, Blanca S. Pineda, EdD, Mei Yi Ng, PhD, John R. Weisz, PhD, Ricardo F. Munoz, PhD, Claudio Gentili, MD, PhD, Soledad Quero, PhD, Eirini Karyotaki, PhD (https://doi.org/10.1016/j.jaac.2020.11.024). It appears in the Journal of the American Academy of Child and Adolescent Psychiatry, volume 60, issue 9 (September 2021), published by Elsevier.
Copies of this paper are available to credentialed journalists upon request; please contact the JAACAP Editorial Office at [email protected] or +1 202 587 9674. Journalists wishing to interview the authors may contact Pim Cuijpers, PhD at [email protected]
Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) is the official publication of the American Academy of Child and Adolescent Psychiatry. JAACAP is the leading journal focusing exclusively on today's psychiatric research and treatment of the child and adolescent. Published twelve times per year, each issue is committed to its mission of advancing the science of pediatric mental health and promoting the care of youth and their families.
The Journal's purpose is to advance research, clinical practice, and theory in child and adolescent psychiatry. It is interested in manuscripts from diverse viewpoints, including genetic, epidemiological, neurobiological, cognitive, behavioral, psychodynamic, social, cultural, and economic. Studies of diagnostic reliability and validity, psychotherapeutic and psychopharmacological treatment efficacy, and mental health services effectiveness are encouraged. The Journal also seeks to promote the well-being of children and families by publishing scholarly papers on such subjects as health policy, legislation, advocacy, culture and society, and service provision as they pertain to the mental health of children and families.
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.
In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.
Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.